Research, Malaria Elimination

GenMoz

P. falciparum genomic intelligence in Mozambique

Duration
2021-2024
Coordinator
Alfredo Mayor (ISGlobal)
Funded by
Bill and Melinda Gates Foundation


Mozambique is among the ten countries with the highest burden of malaria worldwide. At the same time, the National Malaria Control Program (NMCP) of Mozambique seeks to accelerate elimination in the south, where transmission is lowest. NMCP is currently working with partners to set up a high-resolution surveillance system that can drive decision-making across all transmission strata through strengthening of routine data quality, data use and data to action packages. However, decisions become more complex as control reveals heterogeneity and better tools are required for a strategic use of information to drive impact.

The overall aim of the GenMoz project is to build malaria genomic capacities in Mozambique in order to increase the actionable intelligence for making programmatic decisions on the optimal mix of control and elimination measures in Mozambique. The project proposes a participatory approach engaging all parts of the health system to promote a culture of genetic data use and increase the public health impact, while leveraging ongoing activities and existing capacity in Mozambique.

We will first develop analytical and interpretive genomic capacities at the Manhiça Health Research Center (CISM), an institution with extensive experience in malaria research and a pivotal role in contributing to the development of the Mozambican Ministry of Health's overall health policy. We will then integrate genomic intelligence in the NMCP’s strategic and operational activities through:

  1.  Embedding genetic surveillance on ongoing and future routine control and elimination strategies (e.g. use of routine samples).
  2.  The integration of genomic surveillance onto the Integrated Malaria Information Storage System (iMISS) for analysing, visualising and generating data for action (e.g. through genetic surveillance dashboards) at the appropriate granularity level.

The project will be conducted by the Manhiça Health Research Center (Mozambique) in close collaboration with ISGlobal, Malaria Consortium, the University of California-San Francisco and the Institute of Disease Modelling.

Total Funding

5 910 781 USD dollars

Team

Centro de Investigação em Saúde de Manhiça (CISM)

  • Francisco Saúte
  • Pedro Aide
  • Gloria Matambisso
  • Meritxell Molinos
  • Delfino Vubil
  • Arsenio Nhacolo

National Malaria Control Program in Mozambique:

  • Baltazar Candrinho

University of California San Francisco:

  • Bryan Greenhouse

Malaria Consortium

  • Arantxa Roca

Institute of Disease Modelling

  • Caitlin Bever
  • Josh Proctor

Instituto de Biomedicina de Valencia (IBV-CSIC)

  • Iñaki Comas

 

 

 

 

 

Our Team

Principal Investigator (PI)

ISGlobal Team

See More

Other projects

See Past Projects

MESA

The Malaria Eradication Scientific Alliance - MESA is dedicated to advancing the science of malaria eradication.

RTS,S Vaccine Immunology Study

Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial

MiPMon

Pregnant women as a sentinel group for malaria surveillance in an era of changing malaria transmission

AlphaGal

Exploration of the singularities of the sugar nucleotide metabolism and description of novel glycosylation pathways in the malaria parasite

TIPTOP

Transforming IPT for optimal pregnancy

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

ECO

Enhanced and equitable coverage of COVID-19 testing and treatment in Bolivia and Paraguay

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

G_SensMalaria

Portable Graphene Multiplex Electrochemical Sensor for Rapid Detection of Severe Malaria